Positron emission tomography (PET) assessment of renal perfusion

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Positron emission tomography (PET) is a radionuclide imaging technique that allows noninvasive mapping of radiopharmaceutical concentrations in three-dimensional space. PET methods have been described for imaging and quantification of renal perfusion using cyclotron-produced 15O-water and 13N-ammonia, as well as using generator-produced 82RbCl and 62Cu-ETS. Although the majority of clinical PET facilities will lack the in-house biomedical cyclotron needed for 15O and 13N production, the generator-produced tracers are available to virtually any clinical site with a PET camera. Studies with these radiopharmaceuticals have largely focused on methodologic issues, and agent validation for renal blood flow measurements. However, the resulting PET methods for quantification of renal perfusion do appear suitable for application to both research and clinical problems in renal pathophysiology.

Original languageEnglish
Pages (from-to)291-299
Number of pages9
JournalSeminars in Nephrology
Volume31
Issue number3
DOIs
StatePublished - May 2011

Fingerprint

Positron-Emission Tomography
Perfusion
Kidney
Cyclotrons
Radiopharmaceuticals
Renal Circulation
Ammonia
Radionuclide Imaging
Water
Research

Keywords

  • Blood flow
  • Nuclear medicine
  • PET
  • Radiopharmaceutical
  • Renal perfusion

ASJC Scopus subject areas

  • Nephrology

Cite this

Positron emission tomography (PET) assessment of renal perfusion. / Green, Mark; Hutchins, Gary.

In: Seminars in Nephrology, Vol. 31, No. 3, 05.2011, p. 291-299.

Research output: Contribution to journalArticle

@article{e892e7e61f27465e8ecd65da257d6f3a,
title = "Positron emission tomography (PET) assessment of renal perfusion",
abstract = "Positron emission tomography (PET) is a radionuclide imaging technique that allows noninvasive mapping of radiopharmaceutical concentrations in three-dimensional space. PET methods have been described for imaging and quantification of renal perfusion using cyclotron-produced 15O-water and 13N-ammonia, as well as using generator-produced 82RbCl and 62Cu-ETS. Although the majority of clinical PET facilities will lack the in-house biomedical cyclotron needed for 15O and 13N production, the generator-produced tracers are available to virtually any clinical site with a PET camera. Studies with these radiopharmaceuticals have largely focused on methodologic issues, and agent validation for renal blood flow measurements. However, the resulting PET methods for quantification of renal perfusion do appear suitable for application to both research and clinical problems in renal pathophysiology.",
keywords = "Blood flow, Nuclear medicine, PET, Radiopharmaceutical, Renal perfusion",
author = "Mark Green and Gary Hutchins",
year = "2011",
month = "5",
doi = "10.1016/j.semnephrol.2011.05.008",
language = "English",
volume = "31",
pages = "291--299",
journal = "Seminars in Nephrology",
issn = "0270-9295",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Positron emission tomography (PET) assessment of renal perfusion

AU - Green, Mark

AU - Hutchins, Gary

PY - 2011/5

Y1 - 2011/5

N2 - Positron emission tomography (PET) is a radionuclide imaging technique that allows noninvasive mapping of radiopharmaceutical concentrations in three-dimensional space. PET methods have been described for imaging and quantification of renal perfusion using cyclotron-produced 15O-water and 13N-ammonia, as well as using generator-produced 82RbCl and 62Cu-ETS. Although the majority of clinical PET facilities will lack the in-house biomedical cyclotron needed for 15O and 13N production, the generator-produced tracers are available to virtually any clinical site with a PET camera. Studies with these radiopharmaceuticals have largely focused on methodologic issues, and agent validation for renal blood flow measurements. However, the resulting PET methods for quantification of renal perfusion do appear suitable for application to both research and clinical problems in renal pathophysiology.

AB - Positron emission tomography (PET) is a radionuclide imaging technique that allows noninvasive mapping of radiopharmaceutical concentrations in three-dimensional space. PET methods have been described for imaging and quantification of renal perfusion using cyclotron-produced 15O-water and 13N-ammonia, as well as using generator-produced 82RbCl and 62Cu-ETS. Although the majority of clinical PET facilities will lack the in-house biomedical cyclotron needed for 15O and 13N production, the generator-produced tracers are available to virtually any clinical site with a PET camera. Studies with these radiopharmaceuticals have largely focused on methodologic issues, and agent validation for renal blood flow measurements. However, the resulting PET methods for quantification of renal perfusion do appear suitable for application to both research and clinical problems in renal pathophysiology.

KW - Blood flow

KW - Nuclear medicine

KW - PET

KW - Radiopharmaceutical

KW - Renal perfusion

UR - http://www.scopus.com/inward/record.url?scp=79960571504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960571504&partnerID=8YFLogxK

U2 - 10.1016/j.semnephrol.2011.05.008

DO - 10.1016/j.semnephrol.2011.05.008

M3 - Article

C2 - 21784278

AN - SCOPUS:79960571504

VL - 31

SP - 291

EP - 299

JO - Seminars in Nephrology

JF - Seminars in Nephrology

SN - 0270-9295

IS - 3

ER -